Urologix Revenue and Competitors
Estimated Revenue & Valuation
- Urologix's estimated annual revenue is currently $15M per year.
- Urologix's estimated revenue per employee is $300,000
- Urologix's total funding is $100M.
Employee Data
- Urologix has 50 Employees.
- Urologix grew their employee count by 0% last year.
Urologix's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Director Operations | Reveal Email/Phone |
3 | Director Global Sales | Reveal Email/Phone |
4 | Director Marketing | Reveal Email/Phone |
Urologix Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $31800M | 109578 | 4% | $367M | $146B |
What Is Urologix?
Urologix, Inc., based in Minneapolis, develops, manufactures and markets minimally invasive medical products for the treatment of urological disorders. The Company has developed and offers non-surgical, anesthesia-free, catheter- based treatments that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia (BPH), a condition that affects more than 23 million men worldwide. Urologix markets its products under the Targis(TM) and Prostatron(R) names. Both systems utilize Cooled ThermoTherapy(TM) - targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort -- and provide safe, effective, lasting relief of the symptoms of BPH.
keywords:N/A
$100M
Total Funding
50
Number of Employees
$15M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Urologix News
Ltd., Teleflex Inc., Urologix LLC, and Urotech Devices. Also, the urology devices market analysis report includes information on upcoming...
Other Companies in Plymouth
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.4M | 50 | 14% | N/A |
#2 | $6M | 50 | 0% | N/A |
#3 | $12.4M | 51 | 2% | N/A |
#4 | $16.2M | 51 | 9% | N/A |
#5 | $12.4M | 51 | 9% | N/A |